All In MedTech

FDA Clearance Tracker · P040001-S021

X-STOP LTOS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 12, 2014 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 12, 2014

Approved

Time to decision

494 days

Received Aug 5, 2013. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P040001-S021
Device name
X-STOP LTOS
Applicant location
Memphis, TN
Received
Aug 5, 2013
Decided
Dec 12, 2014
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Labeling Change - PAS
Original approval
P040001

Device type

Device class
Class III

Every decision under product code NQO

FDA's approval statement

As written in FDA's record.

APPROVAL FOR AN UPDATE TO THE X STOP® INTERSPINOUS SPACER SYSTEM LABELING TO REFLECT THE RESULTS FROM THE LONG TERM OUTCOMES STUDY (LTOS) THAT WAS CONDUCTED AS A POSTAPPROVAL STUDY REQUIREMENT.

Source documents

Other decisions for Medtronic Sofamor Danek, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

2 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.